O-581
O-224 is a synthetic cannabinoid compound that has been studied for its potential effects on the endocannabinoid system. It is a derivative of the well-known cannabinoid THC (tetrahydrocannabinol), which is the primary psychoactive component of cannabis. O-224 is primarily used in research settings to explore the pharmacological properties of cannabinoids and their potential therapeutic applications.
Chemical Structure and Properties[edit | edit source]
O-224 is a chemical analog of THC, with modifications to its molecular structure that alter its binding affinity and activity at cannabinoid receptors. The precise chemical structure of O-224 includes modifications that enhance its selectivity and potency at the CB1 receptor, a key component of the endocannabinoid system.
Pharmacology[edit | edit source]
O-224 acts as a potent agonist at the CB1 receptor, which is predominantly found in the central nervous system. This receptor is responsible for mediating many of the psychoactive effects of cannabinoids. The binding of O-224 to the CB1 receptor results in the activation of intracellular signaling pathways that can influence various physiological processes, including pain perception, mood regulation, and appetite control.
Research and Applications[edit | edit source]
Research on O-224 has focused on its potential therapeutic applications, particularly in the areas of pain management, neurological disorders, and psychiatric conditions. Studies have shown that O-224 may have analgesic properties, making it a candidate for the development of new pain relief medications. Additionally, its effects on mood and cognition are being explored for potential use in treating conditions such as anxiety and depression.
Safety and Legal Status[edit | edit source]
As a research chemical, O-224 is not approved for medical use in humans. Its safety profile is not well-established, and it is typically used in controlled laboratory settings. The legal status of O-224 varies by jurisdiction, and it is important for researchers to comply with local regulations when conducting studies involving this compound.
Also see[edit | edit source]
- Cannabinoid receptor
- Endocannabinoid system
- Synthetic cannabinoids
- Tetrahydrocannabinol (THC)
- Cannabis research
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
